|
Index of reports
> Cases with Platelet Count Decreased (91)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin where reactions include platelet count decreased. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 91 Next >>
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Periorbital Oedema, Syncope, Anaemia, Platelet Count Decreased, Dizziness, Rash, Asthenia
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-05
Pegasys
Dosage: 90 a?g/kg, unk
Ribavirin
Dosage: 200 mg, qd
Start date: 2012-08-08
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-05
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
Other drugs received by patient: Vitamin E BAR; Hydroxyzine HCL; Escitalopram; Femring MIS; Vitamin D; Progesterone; Lexapro; Ascorbic Acid
Possible Ribavirin side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 67 year old female
Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.94 a?g/kg, unk
Start date: 2012-04-06
End date: 2012-04-26
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-03-30
PEG-Intron
Dosage: 1.13 a?g/kg, unk
Start date: 2012-04-27
End date: 2012-05-10
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-05-11
End date: 2012-08-02
PEG-Intron
Dosage: 1.5 a?g/kg, unk
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-03-29
PEG-Intron
Start date: 2012-05-11
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-04-19
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-08-02
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
VX-950
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-04-13
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-22
VX-950
Dosage: 2250 mg, qd
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine
Possible Ribavirin side effects in 49 year old female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 49 year old female
Reactions: Haematocrit Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
Neupogen
Dosage: unk unk, 2 times/wk
Indication: Hepatitis C
Peginterferon Alfa-2A
Dosage: 90 mug, qwk
Indication: Hepatitis C
Start date: 2012-04-13
Ribavirin
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2012-04-13
Other drugs received by patient: Ribavirin; Peginterferon Alfa-2A
Possible Ribavirin side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-14
Patient: 68 year old female
Reactions: Dizziness Postural, Pyrexia, Haemoglobin Decreased, Abdominal Discomfort, Agranulocytosis, Blood Uric Acid Decreased, Diarrhoea, Platelet Count Decreased, Neutropenia, Cough
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Start date: 2012-05-22
End date: 2012-06-05
Peginterferon Alfa-2A
Start date: 2012-06-12
End date: 2012-06-12
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-05-15
Peginterferon Alfa-2A
Start date: 2012-06-19
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-06-11
Ribavirin
Administration route: Oral
Start date: 2012-06-19
Ribavirin
Administration route: Oral
Start date: 2012-06-12
End date: 2012-06-18
Telavic (Telaprevir)
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-05-21
Telavic (Telaprevir)
Administration route: Oral
Start date: 2012-05-22
End date: 2012-07-31
Other drugs received by patient: Januvia; Myser Ointment; Allopurinol; Restamin; Actos; Urso 250; Glimepiride; Miglitol; Valsartan and Hydrochlorothiazide
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-13
Patient: male
Reactions: Haemorrhage Urinary Tract, Anaemia, Presyncope, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-06-01
Ribavirin
Indication: Hepatitis C
Start date: 2012-06-01
Telaprevir
Indication: Hepatitis C
Start date: 2012-06-01
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Dysgeusia, White Blood Cell Count Decreased, Pruritus, Diarrhoea, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Ribavirin
Dosage: 400 mg, unk
Victrelis
Dosage: 4 df (800 mg) tid,every 7-9 hours
Administration route: Oral
Other drugs received by patient: Omega-3-Acid Ethyl Esters; Vitamins (Unspecified)
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: male, weighing 90.3 kg (198.8 pounds)
Reactions: Pruritus, Head Injury, Eczema, Fall, Fatigue, Skin Ulcer, Basal Cell Carcinoma, Thrombocytopenia, Skeletal Injury, Decreased Appetite, Rash Generalised, Skin Disorder, Hypotonia, Blood Disorder, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased, Respiratory Tract Infection
Drug(s) suspected as cause:
Pegasys
Start date: 2012-04-01
Pegasys
Start date: 2011-08-03
End date: 2012-06-01
Pegasys
Indication: Hepatitis C
Start date: 2011-08-03
End date: 2012-07-01
Pegasys
Indication: HIV Infection
Start date: 2011-11-02
Pegasys
Start date: 2011-03-08
End date: 2012-01-06
Ribavirin
Administration route: Oral
Start date: 2011-08-03
End date: 2012-06-01
Ribavirin
Administration route: Oral
Start date: 2011-11-02
Ribavirin
Dosage: in divided doses
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-03
End date: 2012-07-01
Trazodone HCL
Trazodone HCL
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Fenofibrate; Truvada; Gabapentin; Lexapro; Lipitor; Zofran; Lomotil; Trazodone Hydrochloride; Reyataz
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: female, weighing 105.3 kg (231.7 pounds)
Reactions: Weight Decreased, Folliculitis, Visual Acuity Reduced, Cyst, Photopsia, Menstruation Irregular, Depression, Haematoma, Decreased Appetite, Vomiting, Nausea, Dental Caries, Gastric Haemorrhage, Hypomenorrhoea, Panic Attack, Blood Potassium Decreased, Visual Impairment, Insomnia, Platelet Count Decreased, Polymenorrhoea
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-07-13
Pegasys
Start date: 2011-09-14
End date: 2012-06-06
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-13
Ribavirin
Administration route: Oral
Start date: 2012-05-14
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-05
Patient:
Reactions: White Blood Cell Count Decreased, Dysgeusia, Vomiting, Nausea, RED Blood Cell Count Decreased, Malnutrition, Platelet Count Decreased, Memory Impairment, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Ribavirin
Dosage: unk
Administration route: Oral
Victrelis
Administration route: Oral
Possible Ribavirin side effects in male
Reported by a physician from United States on 2012-08-03
Patient: male
Reactions: White Blood Cell Count Decreased, Nausea, Head Injury, Pain, Blood Count Abnormal, Neck Injury, Fall, Fatigue, Limb Injury, RED Blood Cell Count Decreased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Boceprevir
Indication: Hepatitis C
Start date: 2012-04-28
Pegasys
Indication: Hepatitis C
Start date: 2012-03-30
Pegasys
Start date: 2012-05-11
Ribavirin
Start date: 2012-05-03
Ribavirin
Indication: Hepatitis C
Start date: 2012-03-30
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02
Patient:
Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 ?g, qw
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-03-13
Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: male
Reactions: Blindness Unilateral, Platelet Count Decreased
Drug(s) suspected as cause:
Boceprevir
Indication: Hepatitis C
End date: 2012-07-24
Pegasys
End date: 2012-07-24
Pegasys
Indication: Hepatitis C
Start date: 2012-06-12
Ribavirin
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-07-24
Possible Ribavirin side effects in 58 year old male
Reported by a physician from United States on 2012-07-31
Patient: 58 year old male
Reactions: White Blood Cell Count Decreased, Agitation, Waxy Flexibility, Restlessness, Mutism, Alanine Aminotransferase Increased, Pancytopenia, Stupor, Eating Disorder, Irritability, Aspartate Aminotransferase Increased, Platelet Count Decreased, Musculoskeletal Stiffness, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: weekly (150 mcg), subcutaneous
Indication: Hepatitis C
Ribavirin
Dosage: daily (1200 mg), oral
Administration route: Oral
Indication: Hepatitis C
Other drugs received by patient: Acetaminophen; Vitamin D; Sildenafil Citrate
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Haematochezia, Haemoglobin Decreased, Abdominal Discomfort, Fatigue, RED Blood Cell Count Decreased, Haemorrhoids, Flatulence, Platelet Count Decreased, Memory Impairment, Blood Pressure Decreased, Abdominal Pain Upper, Faeces Discoloured
Adverse event resulted in: death
Drug(s) suspected as cause:
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-14
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-11
Other drugs received by patient: Pegasys
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Brazil on 2012-07-26
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Dysentery, Diarrhoea, Oedema Peripheral, Abdominal Distension, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 unk, unk
Start date: 2012-06-16
PEG-Intron
Dosage: 120 microgram, unk
Indication: Hepatitis C
Start date: 2012-05-26
End date: 2012-06-15
Ribavirin
Dosage: 2 tablets, bid
Administration route: Oral
Start date: 2002-01-01
End date: 2002-01-01
Ribavirin
Dosage: 2 tablets, qam
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Ribavirin
Dosage: 1 tablet, qpm
Administration route: Oral
Start date: 2012-01-01
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-16
Other drugs received by patient: Filgrastim; Epoetin
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: female, weighing 74.8 kg (164.7 pounds)
Reactions: Anaemia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg qweek sq
Indication: Hepatitis C
Start date: 2012-05-16
End date: 2012-07-01
Ribavirin
Dosage: 600 mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-16
End date: 2012-07-01
Other drugs received by patient: Incivek
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-26
Patient:
Reactions: Back Pain, Vomiting, Pain in Extremity, Nausea, Musculoskeletal Pain, Headache, Haemoglobin Decreased, Abdominal Distension, Platelet Count Decreased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-01-09
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-16
Other drugs received by patient: Pegasys
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient: male
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Incivek
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-10
Patient: male, weighing 90.3 kg (198.8 pounds)
Reactions: Pruritus, Head Injury, Eczema, Fall, Fatigue, Skin Ulcer, Basal Cell Carcinoma, Thrombocytopenia, Skeletal Injury, Decreased Appetite, Rash Generalised, Skin Disorder, Hypotonia, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased, Respiratory Tract Infection
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-03
Pegasys
Start date: 2012-04-01
Pegasys
Indication: HIV Infection
Start date: 2011-11-02
Pegasys
Start date: 2011-08-03
End date: 2012-06-01
Pegasys
Start date: 2011-03-08
End date: 2012-01-06
Ribavarin
Administration route: Oral
Start date: 2011-08-03
End date: 2012-06-01
Ribavirin
Administration route: Oral
Start date: 2011-11-02
Ribavirin
Dosage: in divided doses
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-03
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Trazodone Hydrochloride
Other drugs received by patient: Reyataz; Truvada; Lomotil; Gabapentin; Lipitor; Fenofibrate; Trazodone HCL; Lexapro; Zofran
Possible Ribavirin side effects in 54 year old male
Reported by a pharmacist from United States on 2012-07-09
Patient: 54 year old male
Reactions: Oedema Peripheral, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg qw sq
Indication: Hepatitis C
Start date: 2011-11-12
End date: 2012-06-22
Ribavirin
Dosage: 600 mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-12
End date: 2012-06-22
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-09
Patient: female
Reactions: White Blood Cell Count Decreased, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-11
Pegasys
Ribavirin
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-11
Possible Ribavirin side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05
Patient: 61 year old female
Reactions: Lymphocyte Percentage Decreased, Confusional State, Blood Albumin Decreased, Headache, Blood Calcium Decreased, Haematocrit Decreased, Malaise, RED Blood Cell Count Decreased, Dizziness, Depression, Blood Bicarbonate Increased, Crying, Nausea, Febrile Neutropenia, Streptococcus Test Positive, Eye Pain, Haemoglobin Decreased, Anxiety, Platelet Count Decreased, Bronchitis, Klebsiella Test Positive, Leukopenia, Staphylococcus Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.4 ml, qw
Indication: Hepatitis C
Start date: 2012-04-17
PEG-Intron
Dosage: 0.4 ml, qw
Indication: Hepatitis C
Start date: 2012-03-20
End date: 2012-04-17
Ribavirin
Dosage: 600 mg, bid
Indication: Hepatitis C
Start date: 2012-03-20
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-20
Other drugs received by patient: Prilosec; Multi-Vitamin; Motrin; Calcium; Clonazepam; Methadone HCL; Vitamin B-12
Possible Ribavirin side effects in 62 year old male
Reported by a physician from France on 2012-07-05
Patient: 62 year old male, weighing 87.0 kg (191.4 pounds)
Reactions: Haemoglobin Decreased, Platelet Count Decreased, Viith Nerve Paralysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 130 mg/kg;qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-24
End date: 2011-12-05
Ribavirin
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-24
End date: 2011-12-05
Victrelis
Dosage: 800 mg;tid
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-24
End date: 2011-12-05
Other drugs received by patient: Zyprexa; Cymbalta; Metformin HCL; Tocoferol
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05
Patient: male
Reactions: RED Blood Cell Count Decreased, Haemorrhage, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-14
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-14
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-11
Other drugs received by patient: Omeprazole; Lorazepam
Possible Ribavirin side effects in 65 year old male
Reported by a physician from Australia on 2012-07-02
Patient: 65 year old male
Reactions: Haemoglobin Decreased, Drug Dose Omission, Platelet Count Decreased, Oesophageal Rupture, Prothrombin Time Prolonged, Neutrophil Count Decreased, Haematemesis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 mg;qw;sc
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-25
Patient: female
Reactions: Alopecia, Thyroid Disorder, Platelet Count Decreased, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-11-25
End date: 2012-05-10
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-25
End date: 2012-05-10
Telaprevir
Indication: Hepatitis C
Start date: 2011-11-25
End date: 2012-02-10
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22
Patient: female
Reactions: White Blood Cell Count Decreased, Blood Bilirubin Increased, Glossodynia, Pain, Erythema, Oral Discomfort, Haemoglobin Decreased, Dysgeusia, Hypoaesthesia Oral, Oral Pain, Diarrhoea, Blood Uric Acid Increased, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-01-02
Ribavirin
Indication: Hepatitis C
Start date: 2012-01-02
Victrelis
Indication: Hepatitis C
Start date: 2012-02-05
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-19
Patient: female
Reactions: Weight Decreased, Vomiting, Nausea, Dental Caries, Visual Acuity Reduced, Cyst, Photopsia, Gastric Haemorrhage, Hypomenorrhoea, Menstruation Irregular, Blood Potassium Decreased, Visual Impairment, Platelet Count Decreased, Polymenorrhoea, Decreased Appetite
Drug(s) suspected as cause:
Pegasys
Start date: 2011-09-14
End date: 2012-06-06
Pegasys
Indication: Hepatitis C
Start date: 2011-07-13
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-13
Ribavirin
Administration route: Oral
Start date: 2012-05-04
Other drugs received by patient: Citalopram
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-18
Patient: female
Reactions: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased, Menorrhagia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-04-06
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Victrelis
Indication: Hepatitis C
Start date: 2012-05-04
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-18
Patient: female
Reactions: White Blood Cell Count Decreased, Lymphadenopathy, Hospitalisation, Upper Respiratory Tract Infection, Alopecia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-10-28
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-28
Page 1 Next >>
|
